Esterase-Responsive Polyglycerol-Based Nanogels for Intracellular Drug Delivery in Rare Gastrointestinal Stromal Tumors

Rare gastrointestinal stromal tumors (GISTs) are caused by mutations in the KIT and PDGFRA genes. Avapritinib (BLU-285) is a targeted selective inhibitor for mutated KIT and PDGFRA receptors that can be used to treat these tumors. However, there are subtypes of GISTs that exhibit resistance against...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastian Schötz (Author), Adele K. Griepe (Author), Björn B. Goerisch (Author), Sally Kortam (Author), Yael Shammai Vainer (Author), Mathias Dimde (Author), Hanna Koeppe (Author), Stefanie Wedepohl (Author), Elisa Quaas (Author), Katharina Achazi (Author), Avi Schroeder (Author), Rainer Haag (Author)
Format: Book
Published: MDPI AG, 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8a1383d23f0b4eabbd602b9ab5892fd4
042 |a dc 
100 1 0 |a Sebastian Schötz  |e author 
700 1 0 |a Adele K. Griepe  |e author 
700 1 0 |a Björn B. Goerisch  |e author 
700 1 0 |a Sally Kortam  |e author 
700 1 0 |a Yael Shammai Vainer  |e author 
700 1 0 |a Mathias Dimde  |e author 
700 1 0 |a Hanna Koeppe  |e author 
700 1 0 |a Stefanie Wedepohl  |e author 
700 1 0 |a Elisa Quaas  |e author 
700 1 0 |a Katharina Achazi  |e author 
700 1 0 |a Avi Schroeder  |e author 
700 1 0 |a Rainer Haag  |e author 
245 0 0 |a Esterase-Responsive Polyglycerol-Based Nanogels for Intracellular Drug Delivery in Rare Gastrointestinal Stromal Tumors 
260 |b MDPI AG,   |c 2023-11-01T00:00:00Z. 
500 |a 10.3390/ph16111618 
500 |a 1424-8247 
520 |a Rare gastrointestinal stromal tumors (GISTs) are caused by mutations in the KIT and PDGFRA genes. Avapritinib (BLU-285) is a targeted selective inhibitor for mutated KIT and PDGFRA receptors that can be used to treat these tumors. However, there are subtypes of GISTs that exhibit resistance against BLU-285 and thus require other treatment strategies. This can be addressed by employing a drug delivery system that transports a combination of drugs with distinct cell targets. In this work, we present the synthesis of esterase-responsive polyglycerol-based nanogels (NGs) to overcome drug resistance in rare GISTs. Using inverse nanoprecipitation mediated with inverse electron-demand Diels-Alder cyclizations (iEDDA) between dPG-methyl tetrazine and dPG-norbornene, multi-drug-loaded NGs were formed based on a surfactant-free encapsulation protocol. The obtained NGs displayed great stability in the presence of fetal bovine serum (FBS) and did not trigger hemolysis in red blood cells over a period of 24 h. Exposing the NGs to Candida Antarctica Lipase B (CALB) led to the degradation of the NG network, indicating the capability of targeted drug release. The bioactivity of the loaded NGs was tested in vitro on various cell lines of the GIST-T1 family, which exhibit different drug resistances. Cell internalization with comparable uptake kinetics of the NGs could be confirmed by confocal laser scanning microscopy (CLSM) and flow cytometry for all cell lines. Cell viability and live cell imaging studies revealed that the loaded NGs are capable of intracellular drug release by showing similar IC<sub>50</sub> values to those of the free drugs. Furthermore, multi-drug-loaded NGs were capable of overcoming BLU-285 resistance in T1-α-D842V + G680R cells, demonstrating the utility of this carrier system. 
546 |a EN 
690 |a nanogels 
690 |a drug delivery 
690 |a GIST 
690 |a iEDDA 
690 |a polyglycerol 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 16, Iss 11, p 1618 (2023) 
787 0 |n https://www.mdpi.com/1424-8247/16/11/1618 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/8a1383d23f0b4eabbd602b9ab5892fd4  |z Connect to this object online.